Citryll

Treating Inflammatory Diseases

Citryll is a biotech company in Oss, Netherlands, founded in 2015. It has 1 recorded funding round, most recently a Series B in December 2024.

Headquarters
Oss, North Brabant
Employees
11–50
Founded
2015
Last Round
Series BDec 2024
Rounds
1

Indexed holds 1 funding round and 4 investors for this company. to use credits for reveals, or explore the API.

About

Citryll develops therapies focused on rheumatoid arthritis and hidradenitis suppurativa. Its approach targets ETs by preventing new ones from forming and helping remove those already present. The combination of formation inhibition and enhanced clearance underpins its therapeutic strategy for these inflammatory diseases.

Funding History

Data from Indexed.vcUpdated
Series BSeries BDec 2024
EUR 85.0M

Investors

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Backend ×2
  • DevOps ×1
  • Marketing & SEO ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Neuralink

Neuralink develops investigational implantable brain-computer interfaces that help people with pa...

Fremont, United States201–500Biotech
Series ETotal funding$1.2BJun 2025
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Citryll on Indexed.vc
<a href="https://indexed.vc/companies/citryll"><img src="https://indexed.vc/api/badge/company/citryll" alt="Citryll on Indexed.vc" width="260" height="76" /></a>